OFLOXACIN THERAPY FOR EXPERIMENTAL OSTEOMYELITIS CAUSED BY PSEUDOMONAS-AERUGINOSA

被引:14
作者
NORDEN, CW
NIEDERRITER, K
机构
关键词
D O I
10.1093/infdis/155.4.823
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:823 / 825
页数:3
相关论文
共 5 条
[1]   THE PHARMACOKINETICS AND TISSUE PENETRATION OF OFLOXACIN [J].
LOCKLEY, MR ;
WISE, R ;
DENT, J .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1984, 14 (06) :647-652
[2]   ACTIVITIES OF TOBRAMYCIN AND AZLOCILLIN ALONE AND IN COMBINATION AGAINST EXPERIMENTAL OSTEOMYELITIS CAUSED BY PSEUDOMONAS-AERUGINOSA [J].
NORDEN, CW ;
SHAFFER, MA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (01) :62-65
[3]   CIPROFLOXACIN AS THERAPY FOR EXPERIMENTAL OSTEOMYELITIS CAUSED BY PSEUDOMONAS-AERUGINOSA [J].
NORDEN, CW ;
SHINNERS, E .
JOURNAL OF INFECTIOUS DISEASES, 1985, 151 (02) :291-294
[4]   EXPERIMENTAL OSTEOMYELITIS CAUSED BY PSEUDOMONAS-AERUGINOSA [J].
NORDEN, CW ;
KELETI, E .
JOURNAL OF INFECTIOUS DISEASES, 1980, 141 (01) :71-75
[5]   EXPERIMENTAL OSTEOMYELITIS .4. THERAPEUTIC TRIALS WITH RIFAMPIN ALONE AND IN COMBINATION WITH GENTAMICIN, SISOMICIN, AND CEPHALOTHIN [J].
NORDEN, CW .
JOURNAL OF INFECTIOUS DISEASES, 1975, 132 (05) :493-499